UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVMI
1501
Nova
NVMI
$12.5B
| $7.48M | ﹤0.01% |
27,171
+10,142
| +60% | +$2.06M |
|
|
SLNO
1502
DELISTED
Soleno Therapeutics
SLNO
| $7.46M | ﹤0.01% |
89,005
+48,290
| +119% | +$3.61M |
|
1503
Gildan
GIL
$10.6B
| $7.44M | ﹤0.01% |
151,053
-35,532
| -19% | -$1.63M |
|
1504
ePlus
PLUS
$2.34B
| $7.44M | ﹤0.01% |
103,134
+26,948
| +35% | +$1.77M |
|
1505
Pitney Bowes
PBI
$2.39B
| $7.43M | ﹤0.01% |
681,118
+210,630
| +45% | +$1.98M |
|
1506
Payoneer
PAYO
$2.41B
| $7.43M | ﹤0.01% |
1,084,811
+326,984
| +43% | +$2.22M |
|
1507
Addus HomeCare
ADUS
$2.23B
| $7.42M | ﹤0.01% |
64,397
+12,718
| +25% | +$1.37M |
|
1508
Magna International
MGA
$18.8B
| $7.42M | ﹤0.01% |
192,056
-63,181
| -25% | -$2.23M |
|
1509
Acushnet Holdings
GOLF
$5.45B
| $7.4M | ﹤0.01% |
101,586
+10,049
| +11% | +$678K |
|
1510
Acadia Pharmaceuticals
ACAD
$5.03B
| $7.4M | ﹤0.01% |
342,882
+91,826
| +37% | +$1.71M |
|
1511
Gibraltar Industries
ROCK
$1.49B
| $7.39M | ﹤0.01% |
125,269
+38,334
| +44% | +$2.2M |
|
1512
First Merchants
FRME
$2.67B
| $7.38M | ﹤0.01% |
192,563
+59,778
| +45% | +$2.21M |
|
1513
Popular Inc
BPOP
$11.1B
| $7.35M | ﹤0.01% |
66,721
-5,765
| -8% | -$569K |
|
1514
Freedom Holding
FRHC
$9.49B
| $7.33M | ﹤0.01% |
50,217
+13,149
| +35% | +$1.94M |
|
1515
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$12B
| $7.3M | ﹤0.01% |
306,887
| – | – |
|
1516
CoreCivic
CXW
$3.19B
| $7.3M | ﹤0.01% |
346,320
+125,853
| +57% | +$2.71M |
|
1517
Viavi Solutions
VIAV
$9.66B
| $7.3M | ﹤0.01% |
724,533
+170,169
| +31% | +$1.64M |
|
1518
Scholar Rock
SRRK
$6.44B
| $7.26M | ﹤0.01% |
205,085
+35,260
| +21% | +$1.11M |
|
1519
Standex International
SXI
$4.12B
| $7.26M | ﹤0.01% |
46,402
+6,290
| +16% | +$943K |
|
1520
Agios Pharmaceuticals
AGIO
$1.93B
| $7.23M | ﹤0.01% |
217,402
+70,126
| +48% | +$2.13M |
|
|
FOLD
1521
DELISTED
Amicus Therapeutics
FOLD
| $7.2M | ﹤0.01% |
1,255,803
+183,329
| +17% | +$1.18M |
|
1522
Vertex
VERX
$1.94B
| $7.19M | ﹤0.01% |
203,615
+62,409
| +44% | +$2.37M |
|
1523
Enovis
ENOV
$1.53B
| $7.19M | ﹤0.01% |
229,295
+47,953
| +26% | +$1.59M |
|
1524
DNOW Inc
DNOW
$2.99B
| $7.16M | ﹤0.01% |
482,795
+124,087
| +35% | +$1.89M |
|
1525
City Holding Co
CHCO
$2.04B
| $7.14M | ﹤0.01% |
58,340
+20,055
| +52% | +$2.35M |
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.